RAFIQ AHMED BHAT1, SYED MANZOOR ALI2, YOOSUF ALI ASHRAF MUHAMMAD HUSSENBOCUS3, AKANKSHA RATHI4, JAVAID AKHTER BHAT5, ABDUL ALEEM KHAN6, SYED MAQBOOL2, RAJA SAQIB IQBAL7, MD MONOWARUL ISLAM8, YONGSHENG QU9, YOU ZHANG9, YUXIAO SUN1, WENTAO XIAO9, ABHISHEK TIBREWAL10, CHUANYU GAO1,*
BIOCELL, Vol.46, No.5, pp. 1139-1150, 2022, DOI:10.32604/biocell.2022.016833
- 06 January 2022
Abstract The adverse outcomes of a ventricular heart failure (left, right or biventricular) caused by cardiogenic shock are aggravated by lung oedema and organ mal perfusion. Despite advances in medical sciences, revascularisation and mechanical hemodynamic support have proved ineffective in reducing the mortality rate in such patients. A thorough study of the data available about cardio-vascular diseases reveals that the application of conventional methods of treatment are least helpful to practically restore normal functions of heart when it experiences end-stage systolic ventricular failure. Thus, to overcome the challenges and find alternatives to address this issue, percutaneous… More >
Login
Register
